Courageous Parents, Courageous Children (COACH)

July 24, 2017 updated by: Barbara Pavlova

Transgenerational Prevention of Anxiety in Children at Ultra-high Risk

Anxiety disorders usually start in childhood and adolescence and are associated with social and occupational difficulties in adulthood. Children who have a parent with an anxiety disorder and who find new situations distressing and avoid them are at an increased risk for developing an anxiety disorder. Research suggests that anti-anxiety parenting can help children grow up courageous and calm. It is, however, difficult to parent in an anti-anxiety way when the parent has an anxiety disorder himself or herself.

This research study will test the efficacy of a new program designed to prevent the onset or persistence of anxiety disorders in children at risk for anxiety disorders. The investigators will first help parents learn skills to cope with their own anxiety and then coach them to share these skills with their children and parent in an anti-anxiety way. The goal is to intervene early enough in the children's lives so that they can be free of anxiety disorders and lead happy, healthy and productive lives in adulthood.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Parents:

Inclusion criteria:

Parents will be included if they have a current diagnosis of at least one anxiety disorder, one or more children between the ages two and eight years in their own care, capacity to provide informed consent, and ability to speak English well enough to benefit from the intervention.

Exclusion criteria:

Exclusion criteria for parents are receipt of an adequate course (6 or more sessions) of structured psychological therapy in the past 12 months, or plans to move out of Nova Scotia within the next three years. We will include parents with co-morbid mood disorders. However, those whose mood disorder is the primary complaint will be referred for treatment for their mood before being re-assessed. We will exclude parents with disorders that would interfere with the standard treatment protocol delivery; these include lifetime schizophrenia, autism, intellectual disability and current drug and alcohol use disorder.

Offspring:

Inclusion criteria:

Children are eligible if they are aged two to eight and if they have a score of inhibited temperament (negative emotionality) one standard deviation or more above the mean of an age-matched normative sample on the Laboratory Assessment of Temperament.

Exclusion criteria:

Those with lifetime schizophrenia, autism, general intellectual disability, and current drug and alcohol addiction will be excluded, as these conditions would impact on the standard delivery of the parenting intervention. We will exclude children currently receiving treatment for anxiety.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cognitive behavioural skills training
The intervention will be delivered in two stages: First, the parent with an anxiety disorder will attend between six and sixteen weekly sessions of cognitive behavioural skills training focusing on their own anxiety. They will work on developing behaviours that will help them become less anxious in the long-run and on learning to evaluate danger in a realistic way. Next, the parent will take part in four to eight weekly sessions of anti-anxiety parenting skills training aiming to help them transfer the skills that they learned into parenting their children. In the parenting intervention, the parents will be guided to gradually expose their children to new situations, build communication skills and confidence, in addition to general parenting skills and principles.
NO_INTERVENTION: No intervention
Participants in the control group will receive their usual clinical care and will not be discouraged from seeking any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: One year post randomization
Diagnosis of anxiety disorder in the offspring
One year post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Two years post randomization
Diagnosis of anxiety disorder in the offspring
Two years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Three years post randomization
Diagnosis of anxiety disorder in the offspring
Three years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Five years post randomization
Diagnosis of anxiety disorder in the offspring
Five years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Seven years post randomization
Diagnosis of anxiety disorder in the offspring
Seven years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Ten years post randomization
Diagnosis of anxiety disorder in the offspring
Ten years post randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Teaching Task Battery
Time Frame: One year post randomization
Parenting behaviours
One year post randomization
Teaching Task Battery
Time Frame: Two years post randomization
Parenting behaviours
Two years post randomization
Structured Clinical Interview for DSM-5 diagnoses (SCID-5)
Time Frame: One year post randomization
Diagnosis of anxiety disorder in the parent
One year post randomization
Structured Clinical Interview for DSM-5 diagnoses (SCID-5)
Time Frame: Two years post randomization
Diagnosis of anxiety disorder in the parent
Two years post randomization
Laboratory Temperament Assessment Battery
Time Frame: One year post randomization
Temperament in the offspring
One year post randomization
Laboratory Temperament Assessment Battery
Time Frame: Two years post randomization
Temperament in the offspring
Two years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Three years post randomization
Diagnosis of major mood and psychotic disorders in offspring
Three years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Five years post randomization
Diagnosis of major mood and psychotic disorders in offspring
Five years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Seven years post randomization
Diagnosis of major mood and psychotic disorders in offspring
Seven years post randomization
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Time Frame: Ten years post randomization
Diagnosis of major mood and psychotic disorders in offspring
Ten years post randomization
Global Assessment of Functioning
Time Frame: One year post randomization
Functioning in the offspring
One year post randomization
Global Assessment of Functioning
Time Frame: Two years post randomization
Functioning in the offspring
Two years post randomization
Global Assessment of Functioning
Time Frame: Three years post randomization
Functioning in the offspring
Three years post randomization
Global Assessment of Functioning
Time Frame: Five years post randomization
Functioning in the offspring
Five years post randomization
Global Assessment of Functioning
Time Frame: Seven years post randomization
Functioning in the offspring
Seven years post randomization
Global Assessment of Functioning
Time Frame: Ten years post randomization
Functioning in the offspring
Ten years post randomization
Screen for Child Anxiety Related Disorders
Time Frame: One year post randomization
Anxiety in the offspring - continuous
One year post randomization
Screen for Child Anxiety Related Disorders
Time Frame: Two years post randomization
Anxiety in the offspring - continuous
Two years post randomization
Screen for Child Anxiety Related Disorders
Time Frame: Three years post randomization
Anxiety in the offspring - continuous
Three years post randomization
Screen for Child Anxiety Related Disorders
Time Frame: Five years post randomization
Anxiety in the offspring - continuous
Five years post randomization
Screen for Child Anxiety Related Disorders
Time Frame: Seven years post randomization
Anxiety in the offspring - continuous
Seven years post randomization
Screen for Child Anxiety Related Disorders
Time Frame: Ten years post randomization
Anxiety in the offspring - continuous
Ten years post randomization
Spence Children's Anxiety Scale
Time Frame: One year post randomization
Anxiety in the offspring - continuous
One year post randomization
Spence Children's Anxiety Scale
Time Frame: Two years randomization
Anxiety in the offspring - continuous
Two years randomization
Spence Children's Anxiety Scale
Time Frame: Three years post randomization
Anxiety in the offspring - continuous
Three years post randomization
Spence Children's Anxiety Scale
Time Frame: Five years post randomization
Anxiety in the offspring - continuous
Five years post randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

September 1, 2017

Primary Completion (ANTICIPATED)

September 1, 2020

Study Completion (ANTICIPATED)

September 1, 2020

Study Registration Dates

First Submitted

July 18, 2017

First Submitted That Met QC Criteria

July 19, 2017

First Posted (ACTUAL)

July 21, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 25, 2017

Last Update Submitted That Met QC Criteria

July 24, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1022588

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Disorder

Clinical Trials on Cognitive behavioural skills training

3
Subscribe